Internal Medicine, Infectious Disease · Indianapolis, IN
NPI
1326088212
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
7250 Clearvista Dr, Suite 260
Indianapolis, IN, 46256
Phone (317) 621-1690
Groups this clinician bills Medicare through
Medicare paid, 2024
$81K
1,254 services
Medicare patients, 2024
276
Average age 72
Drug cost, 2024
$4.1M
2,351 prescriptions
Company payments, 2025
$52.55
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Steven A Norris was code 99232 (hospital e&m - subsequent), 677 times for 184 patients. In total Steven A Norris billed 1,254 services in 19 codes, and Medicare paid $81K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-06-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 677 | 184 | $57.23 | $39K |
| 99231 Hospital E&M - Subsequent | Facility | 194 | 115 | $35.67 | $6,920 |
| 99222 Hospital E&M - Initial | Facility | 151 | 139 | $95.25 | $14K |
| 99233 Hospital E&M - Subsequent | Facility | 117 | 42 | $87.47 | $10K |
| 99214 Office E&M - Established | Office | 38 | 31 | $85.60 | $3,253 |
| 99223 Hospital E&M - Initial | Facility | 36 | 31 | $127.67 | $4,596 |
By year: 2022 $99K for 1,538 services; 2023 $83K for 1,404 services; 2024 $81K for 1,254 services.
Medicare prescription drug claims, 2024
In 2024, the drug Steven A Norris prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 361 prescriptions and refills. In total Steven A Norris wrote 2,351 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 361 | 371 | 39 | $1.5M |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 222 | 234 | 22 | $980K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 177 | 183 | 19 | $695K |
| Cephalexin Generic | 83 | 122 | 39 | $2,053 |
| Ceftriaxone Ceftriaxone Sodium | 74 | 74 | 16 | $6,842 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 74 | 110 | 21 | $848 |
| Testosterone Generic | 58 | 62 | Under 11 | $7,727 |
| Acyclovir Generic | 55 | 64 | Under 11 | $311 |
| Doxycycline Hyclate Generic | 54 | 62 | 31 | $574 |
| Cefazolin Sodium Generic | 53 | 53 | Under 11 | $2,469 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 51 | 55 | 36 | $674 |
| Prezcobix Darunavir/Cobicistat | 44 | 52 | Under 11 | $137K |
| Vancomycin Hcl Generic | 41 | 41 | 17 | $3,715 |
| Efavirenz-Emtric-Tenofov Disop Efavirenz/Emtricit/Tenofovr Df | 39 | 67 | Under 11 | $59K |
| Doxycycline Monohydrate Generic | 31 | 37 | Under 11 | $995 |
Brand drugs: 956 claims; generic drugs: 1,395 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Steven A Norris $52.55 ($52.55 in general payments such as food, travel and fees) from 2 companies. The largest payer was Theratechnologies Inc. with $27.43.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.